Global DNA And RNA Banking Services Market Size By Service (Transportation Service, Processing Service, Storage Service), By Specimen Type (Blood, Saliva), By Applications (Therapeutics, Drug Discovery & Clinical Research, Clinical Diagnostics), By End User (Hospitals & Diagnostic Centers, Academic Research, Pharmaceutical & Biotechnology Companies), By Geographic Scope And Forecast

DNA And RNA Banking Services Market Size And Forecast

DNA And RNA Banking Services Market size was valued at USD 5.78 Billion in 2020 and is projected to reach USD 8.59 Billion by 2028, growing at a CAGR of 5.08% from 2021 to 2028.

Looking ahead, we expect the Global DNA And RNA Banking Services Market to grow, thanks to exciting progress in clinical research and a warmer welcome for personalized medicine. Plus, with cancer rates sadly on the rise, there's a greater need to save DNA and RNA samples for later, which should really help the market. Our report offers a complete look at this market. Inside, you'll find an analysis of the key pieces, what's trending, what's helping and hurting the market, who the big players are, and everything else that's shaping the future of DNA and RNA Banking Services globally.

Global DNA And RNA Banking Services Market Definition

DNA and RNA Banking, that's basically how we securely store someone's genetic blueprint for the long haul. Think of DNA banks as repositories where we not only keep this precious material safe but also allow us to compare a person's genetic information over time. Why is this a big deal? Well, scientists can use DNA analysis to get a heads-up about potential genetic illnesses and even confirm someone's identity – super handy for preventive genetics and gene therapy. Usually, we get DNA from blood, but you can also snag it from a cheek swab (saliva) or other tissues. This has really pushed the boundaries of preventive genetics, helping us spot patterns and pinpoint the genes responsible for certain conditions, all thanks to those DNA bank samples.

Knowing which genes are behind our illnesses can empower us to take steps to ease symptoms. This could mean making lifestyle changes, focusing on preventative healthcare, or even exploring gene therapy. The National Center for Biotechnology Information (NCBI) describes a DNA bank as essentially a never-ending supply of stable DNA. This allows researchers to dig into genetic analysis and test fresh ideas about what causes diseases and how to predict/diagnose them, even long after a sample was initially taken. These DNA banks are vital collections where samples are carefully gathered, processed, and stored following really high quality standards.

Data and samples are collected under rigorous standard operating procedures, and illness status, biomarkers, physiological processes, and social and environmental factors are accurately and precisely assessed. DNA quality indicators, such as DNA purity and integrity, must be before employing DNA samples in analytical techniques to ensure their quality and applicability. The ratio between 260 and 280 nm absorbance is used to determine DNA quality. In the case of DNA, a ratio of 1.8 is considered “pure.” If the ratio is significantly smaller (1.6), proteins, phenol, or other pollutants that absorb heavily at or near 280 nm may be present.

Global DNA And RNA Banking Services Market Overview

To find new biomarkers and pave the way for personalized therapy, we really need biospecimens like DNA and RNA. Plus, these cool cell separation technologies are so advanced and systematic that they've basically removed the need for a lot of hands-on work in those translational and clinical studies. And get this - digital technologies and turning biobanks into fully automated systems? That can seriously speed up business growth. All those new and existing imaging biobanks are a huge reason why the Global DNA And RNA Banking Services Market is getting bigger and bigger. Looking ahead, all the progress in clinical research and innovation, plus the increasing popularity of personalized medicine, will likely help the Global DNA And RNA Banking Services Market keep expanding.

It's no secret that cancer cases are on the rise globally, and that's driving the need to keep DNA and RNA samples safe for future research. This need will likely boost the market for DNA and RNA Banking Services worldwide. However, it's not all smooth sailing. We're seeing some roadblocks, like disagreements over the social, ethical, and legal implications of using population samples, and worries about privacy, consent, and how data is shared. But there's also a big opportunity! According to (NCBI), the evolution of molecular biology is fueling research into disease genetics and how they interact with things like environment, lifestyle, and even society.

We wouldn't have come this far without top-notch DNA from lots of people. And because DNA can come from pretty much anywhere, making sure it's good enough is super important before we use it for anything else. So, we took a look at the DNA we get from the most common human samples we work with here—you know, the stuff we might use for molecular testing researchOCT frozen tissue, FFPE tissue, frozen blood, and saliva. Turns out, frozen tissues in OCT are usually the best DNA source, especially when you need those histopathological samples for your studies.

Okay, so the data from our FFPE tissue DNA – you know, the HMW band/smear ratio, the PicoGreen/A260 yield, and even the PCR results – well, they're not looking great. The DNA is pretty degraded, making it hard to work with. Thankfully, projects like the TuBaFrost project make sure we have access to high-quality frozen tissue. But, hey, the good news is that we're getting better at pulling data from those FFPE samples we have stashed in diagnostic archives, giving researchers a brand-new source of stuff to work with! Plus, there are new tissue stabilization methods out there, like the PAXgene Tissue System, which means we can now combine molecular analysis with how the tissue actually looks. Basically, when we're out of frozen tissue, these fixed tissues are becoming super important for research down the road.

Global DNA And RNA Banking Services Market Segmentation Analysis

The Global DNA And RNA Banking Services Market is segmented on the basis of Service, Specimen Type, Applications, End User, And Geography.

DNA And RNA Banking Services Market, By Service

• Transportation Service• Processing Service• Storage Service• Quality Control Service• Data Storage

Based on Service, The market is divided into Transportation Service, Processing Service, Storage Service, Quality Control Service, and Data Storage. From the presence of numerous significant suppliers in the market sector, the Storage Service represented the largest income share. The use of automated Storage Systems allows for the management of high product volumes while also reducing processing time. The market is also driven by storage and distribution. The success of biobanks depends on the long-term preservation and storage of DNA and RNA. It’s critical to keep biological samples in temperature-controlled environments like -196°C, -80°C, -20°C, 2.0°C-8.0°C, and 15.0°C-25.0°C

DNA And RNA Banking Services Market, By Specimen Type

• Blood• Saliva• Others

Okay, so when we look at the market, it's really about the type of sample we're talking aboutBlood, Saliva, and, well, Others. Blood really dominates the market right now because it's just what everyone uses for regular checkups. But don't count out Saliva! Getting a saliva sample is super quick and easy – you don't even need a doctor or nurse. Plus, it's becoming a favorite for cancer research that doesn't involve needles. And get this – whether you take a little blood or a lot, you still get plenty of DNA and RNA. Blood samples are pretty standard, you know, involving a little poke and some special tubes. The best part? Patients don't have to do anything extra for biobanking if you're already drawing blood, making it a really simple process.

DNA And RNA Banking Services Market, By Applications

• Therapeutics• Drug Discovery & Clinical Research• Clinical Diagnostics

Based on Applications, The market is divided into Therapeutics, Drug Discovery & Clinical Research, and Clinical Diagnostics. The market was dominated by Drug Discovery & Clinical Research. Scientific improvements in population stratification and biomarker development are aided by DNA And RNA Banking Services. These programs are essential for the discovery of novel pharmaceuticals as well as the conduct of clinical trials. It helps with inpatient prevention and prediction, as well as therapeutic tracking, follow-up, and optimization. The demand for medication development and clinical trials has increased.

DNA And RNA Banking Services Market, By End User

• Hospitals & Diagnostic Centers• Academic Research• Pharmaceutical & Biotechnology Companies

Based on End User, The market is divided into Hospitals & Diagnostic Centers, Academic Research, and Pharmaceutical & Biotechnology Companies. The DNA And RNA Banking Services business was dominated by academic research. The usefulness of DNA and RNA banks is well understood by translational researchers in academic universities and laboratories Academic and research centers are working to understand the differences between medical processes and human responses. Medical genetic investigations help with drug diagnosis, illness carrier identification, and the risk of developing such conditions. This institution also functions as a biobank, storing, processing, and testing biological material.

DNA And RNA Banking Services Market, By Geography

• North America• Europe• Asia Pacific• Rest of the world

When we look at different regions, the global market for DNA and RNA banking services breaks down into North America, Europe, Asia Pacific, and the rest of the world. Right now, North America holds a pretty big piece of that market. What's really driving growth? Well, the launch of national programs focused on precision medicine is a big one. Think about itDNA and RNA samples are essential for finding biomarkers, which in turn paves the way for tailor-made therapies. Plus, the latest cell separation tech is so advanced that it cuts down on manual work in research and clinical trials. And with digital technologies improving and biobanks becoming fully automated, businesses in this field can really take off.

So, all these imaging biobanks popping up and doing their thing are really fueling the growth of the Global DNA And RNA Banking Services Market. Looking ahead, we're expecting some awesome progress in clinical research and cool new ideas, plus everyone's getting on board with personalized medicine – all of which should help the market get even bigger. And let's not forget the sad reality of increasing cancer rates worldwide; it's driving the need to bank DNA and RNA for future research, and that’s definitely going to boost the DNA And RNA Banking Services Market globally.

Key Players

The “Global DNA And RNA Banking Services Market” study report will provide a valuable insight with an emphasis on the global market including some of the major players such as EasyDNA, DNA Genotek Inc., 23andMe, Inc., Goodcell, ProteoGenex, US Biolab Corporation, Inc., Infinity Biologix, Thermo Fisher Scientific, Inc., deCODE genetics, Brooks Life Sciences, LGC Biosearch Technologies, PreventionGenetics. These market players have attempted a few key drives to widen their market presence and keep a competitive edge in the worldwide market.

Key Developments

• In January 2020, Brooks Life Sciences has expanded its facilities in order to increase sample storage and biobanking. Research institutes and pharmaceutical companies were able to accelerate clinical studies and the development of effective treatments by collecting a larger volume of samples.

• Nov 01, 2021, At ASMS, Thermo Fisher Scientific introduces new mass spectrometry and chromatography solutions.

• Jun 21, 2021, Thermo Fisher Scientific’s (TMO) upgraded Quick to Clinic solution balances speed and quality to accelerate and advance DNA to Investigational New Drug status in as little as 13 months.

• Dec 20, 2021, one of the important players, Thermo Fisher Scientific, released their Automation-Ready kit of DNA and RNA separation for advanced microbiome research.

Report Scope

Top Trending Reports

Research Methodology of Market Research

To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our .

Reasons to Purchase this Report

We dig deep, using both numbers and more nuanced understanding, to break down the market by different groups of customers. We'll give you the dollar value (in USD Billion) for each area we analyze. You'll see which regions and customer groups are poised for the biggest growth and dominance. We'll break down the market region by region, showing you where the product or service is being used and what's driving things locally. We also look at the competition, ranking the major players and highlighting what they've been up tonew offerings, partnerships, expansions, and acquisitions over the last five years. You'll get detailed company profiles with overviews, insights, product comparisons, and SWOT analyses of the key market players. We'll give you our take on the present and future of the market, considering recent events, growth opportunities, and the challenges and roadblocks in both new and established markets. Expect a thorough look at the market from all angles, using Porter's five forces. We also provide insights into the market through a Value Chain analysis. Finally, we'll paint a picture of the market's dynamics, pointing out growth opportunities in the years ahead, and include 6-month post-sales analyst support.

Customization of the Report

• In case of any please connect with our sales team, who will ensure that your requirements are met.